The Broad Institute of MIT and Harvard is a non-profit research institute in Cambridge, Massachusetts. Since its creation in 2004, the Broad has become a global leader in fields including cancer, psychiatric disease, and diabetes, championing innovative genomic approaches and technologies to drive discovery in biomedicine. The Broad’s collaborative, interdisciplinary approach combines the intellectual vibrancy of academia with the technology and scale associated with industry. The Broad supports the open sharing of data, methods, and resources in order to advance discovery. For more information about the Broad Institute, go to broadinstitute.org.

The MBCproject is led by Dr. Nikhil Wagle, MD, a breast cancer oncologist and metastatic breast cancer researcher and directed by Corrie Painter, PhD, a cancer researcher, cancer patient and patient advocate. This project was designed and has been implemented collaboratively with metastatic breast cancer patients, patient advocates, cancer researchers, physicians, and clinical specialists. We leverage the power of the Broad Institute’s resources and the voice of the metastatic breast cancer community in order to focus cutting edge genomic science squarely on people living with metastatic breast cancer. Special thanks to our friends at Playground Inc. for helping to design and develop this website.

About page broad building

Our Advocacy Partners

Logo mbcn
Logo avon
Logo mbca
Logo lbbc
Logo ibcrf
Logo ysc
Logo mbcc
Logo theresas
Logo tnbc
Logo ibc
Logo a4bc
Logo metavivor
Logo metup
Logo tigerlily
Logo susangkomen
Logo bcrf
Logo dslrf
Logo bcsm
Logo hopescarves
MBCN is thrilled to support the Metastatic Breast Cancer Project. By sharing tissue and medical histories, patients can play an active, key role in helping researchers unlock the mysteries of metastatic disease.
Shirley Mertz, President of Metastatic Breast Cancer Network